Brief: Qlife To Develop SARS-Cov-2 Total Antibody Test

Qlife Holding AB

02/06/2020 09:29

June 2 (Reuters) - Qlife Holding AB  QLIFE.ST :
    * QLIFE TO DEVELOP SARS-COV-2 TOTAL ANTIBODY TEST
    * EXPECTS TO BE ABLE TO CE MARK FOR PROFESSIONAL USE LATE
2020 AND
SUBMIT A FILE FOR CE MARK HOME USE DURING Q1 2021.
    * FIRST PHASE OF DEVELOPING ANTIBODY TEST WILL BE OUTSOURCED
TO AN
EXISTING PARTNER AND IS EXPECTED TO TAKE APPROXIMATELY THREE
MONTHS

Source text for Eikon:  ID:nWkr1swtmp 
Further company coverage:  QLIFE.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))